Answers are grounded in this paper and cite their sources.
Background The poultry industry has widely used antibiotics at growth-promoting doses, a practice that has accelerated antimicrobial resistance. However, the effects of prolonged low-dose antibiotic exposure on chicken gut microbiota and systemic metabolism remain inadequately understood. Results Broilers received a broad-spectrum antibiotic cocktail in drinking water, and 16S rRNA sequencing, serum metabolomics, and phenotypic measurements were integrated to investigate antibiotic impacts on the gut microbiota and mechanisms of metabolic regulation. Antibiotic treatment significantly altered the cecal microbial community, marked by reductions in Lactobacillus and butyrate-producing genera and increases in Escherichia-Shigella and Enterococcus ( P <0.05). Functional gene prediction indicated downregulation of carbohydrate and amino acid metabolism pathways alongside upregulation of ABC transporters and quorum sensing systems. Consistent with this functional shift, tryptophan-derived indole metabolites were the most depleted class of circulating metabolites: 5-hydroxyindoxyl sulfate, quinoline 1-oxide and 2,8-quinolinediol were each reduced by 45–53%. Their depletion was accompanied by broad host metabolic remodeling, including significant increases in branched-chain amino acid catabolites , a coordinated reduction of six phospholipid species (FDR < 0.05) with lysophosphatidylcholines declining most consistently, elevated markers of oxidative stress and of antioxidant defense. Trends toward increased fatty acid oxidation and impaired TCA cycle flux were also observed. These metabolic alterations were accompanied by reduced intestinal length and lower immune organ indices. Conclusions Long-term exposure to a broad-spectrum antibiotic cocktail induces gut dysbiosis and depletes microbiota-derived tryptophan–indole metabolites, which is accompanied by systemic metabolic remodeling and impaired intestinal and organ development in broilers. These findings identify microbial tryptophan metabolism as a candidate target for mitigating antibiotic-induced metabolic impairment.
No takes yet. Share an insight, caveat, or question.
Xiong et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: